How do you counsel families of pediatric patients regarding risk of secondary malignancy or IQ changes with cranial radiation using photons?
Are there general ages that you refer to in terms of risk of secondary malignancy or points dropped for IQ over time after treatment, or particular helpful studies (such as the Childhood Cancer Survivorship Study Negalia JNCI 2006 or other newer studies?)
1 Answer
Mednet Member
Radiation Oncology · St Jude Children's Research Hospital
Answered on
It’s a great question as these are two of the scariest things that families face when you relay the potential risks of cranial radiotherapy. Simple things like timing of these topics in the consent discussion can make a difference. Don’t start with the scariest potential risk when doing the consent,...
Join for free or sign in to see the full answer